Skip to content

Vivani Medical VANI Neurostimulation Division — Other Nonoperating Income Expense

Other segment segments

Biopharm Division
-$209K+29.4%
Neuromodulation Division
$42K+2.4%

Similar metrics at other companies

MoonLake Immunotherapeutics logo
MLTXOther Nonoperating Income
$3.21M-54.8%
Vor Biopharma logo
VOROther Nonoperating Income
$2K
OraSure Technologies logo
OSUROther Nonoperating Income
$1.55M-12.9%
Sionna Therapeutics, Inc. Common Stock logo
SIONOther Nonoperating Income
$0-100%
Sidus Space, Inc. logo
SIDUOther Nonoperating Income
$81.85K-18.2%
Annexon logo
ANNXInterest And Other Non Operating Income Expense
$1.91M-37.3%

Other financials

Income statement

See full
Revenue-
Gross profit$130.0K
Operating income-$6.8M-4.0%
Net income-$6.8M-7.6%
EPS (diluted)-$0.08+27.3%

Balance sheet

See full
Cash & equivalents$19.0M+57.7%
Total debt$18.3M-3.5%
Total equity$19.1M+64.2%
Total assets$42.4M+19.5%

Cash flow

See full
Operating cash flow-$6.2M-20.0%
CapEx$3.0K-40.0%
Free cash flow-$6.2M-19.9%

Valuation

See full
Market cap$106.93M+40.0%
Enterprise value$106.17M+19.3%

Profitability

See full
Gross margin36.3%
Operating margin-1,004.9%
Net margin-994.1%
FCF margin-832.3%

Returns & leverage

See full
Return on equity-176.4%+175pp
Debt / equity-0.7×
Current ratio3.2×+0.8×

Where this comes from

Reported directly by Vivani Medical in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vivani Medical's neurostimulation division — other nonoperating income expense.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vivani Medical's neurostimulation division — other nonoperating income expense?
Vivani Medical (VANI) reported neurostimulation division — other nonoperating income expense of $31.5K in Q4 2025.
How has Vivani Medical's neurostimulation division — other nonoperating income expense changed year-over-year?
Vivani Medical's neurostimulation division — other nonoperating income expense increased by 180.8% year-over-year, from -$39K to $31.5K.
What is the long-term trend for Vivani Medical's neurostimulation division — other nonoperating income expense?
Over 2 years (2023 to 2025), Vivani Medical's neurostimulation division — other nonoperating income expense has grown at a 5.6% compound annual growth rate (CAGR), from -$113K to $126K.
What does neurostimulation division — other nonoperating income expense mean?
Includes financial items outside the core business operations of the neurostimulation division, such as interest income, interest expense, or foreign exchange gains and losses. This metric provides insight into the division's peripheral financial activities and non-core cash flow impacts. It helps isolate the performance of the primary business from incidental financial events.